Results
|
|
3501.
|
Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases. [electronic resource] by
- Nozawa, Hiroaki
- Ishihara, Soichiro
- Kawai, Kazushige
- Hata, Keisuke
- Kiyomatsu, Tomomichi
- Tanaka, Toshiaki
- Nishikawa, Takeshi
- Otani, Kensuke
- Yasuda, Koji
- Sasaki, Kazuhito
- Murono, Koji
- Nakajima, Jun
- Watanabe, Toshiaki
Producer: 20170308
In:
Oncology vol. 92
Availability: No items available.
|
|
|
3502.
|
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. [electronic resource] by
- Cascinu, Stefano
- Rosati, Gerardo
- Nasti, Guglielmo
- Lonardi, Sara
- Zaniboni, Alberto
- Marchetti, Paolo
- Leone, Francesco
- Bilancia, Domenico
- Iaffaioli, Rosario Vincenzo
- Zagonel, Vittorina
- Giordano, Monica
- Corsi, Domenico C
- Ferraú, Francesco
- Labianca, Roberto
- Ronzoni, Monica
- Scartozzi, Mario
- Galli, Francesca
Producer: 20170911
In:
European journal of cancer (Oxford, England : 1990) vol. 83
Availability: No items available.
|
|
|
3503.
|
|
|
|
3504.
|
|
|
|
3505.
|
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study. [electronic resource] by
- Segelov, Eva
- Thavaneswaran, Subotheni
- Waring, Paul M
- Desai, Jayesh
- Robledo, Kristy P
- Gebski, Val J
- Elez, Elena
- Nott, Louise M
- Karapetis, Christos S
- Lunke, Sebastian
- Chantrill, Lorraine A
- Pavlakis, Nick
- Khasraw, Mustafa
- Underhill, Craig
- Ciardiello, Fortunato
- Jefford, Michael
- Wasan, Harpreet
- Haydon, Andrew
- Price, Timothy J
- van Hazel, Guy
- Wilson, Kate
- Simes, John
- Shapiro, Jeremy D
Producer: 20170731
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34
Availability: No items available.
|
|
|
3506.
|
The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent. [electronic resource] by
- Scicinski, Jan
- Fisher, George
- Carter, Corey
- Cho-Phan, Cheryl
- Kunz, Pamela
- Ning, Shoucheng
- Knox, Susan
- Oronsky, Bryan
- Caroen, Scott
- Parker, Christopher
- Fanger, Gary
- Reid, Tony
Producer: 20180110
In:
Redox biology vol. 5
Availability: No items available.
|
|
|
3507.
|
|
|
|
3508.
|
Synergistic Effects of Olaparib and DNA-damaging Agents in Oesophageal Squamous Cell Carcinoma Cell Lines. [electronic resource] by
- Miyamoto, Keisuke
- Minegaki, Tetsuya
- Tanahashi, Mami
- Yamamoto, Ayaka
- Moriyama, Yumi
- Wada, Akari
- Matsumoto, Ayaka
- Ota, Keisuke
- Tanaka, Mai
- Masuda, Utako
- Tsujimoto, Masayuki
- Nishiguchi, Kohshi
Producer: 20190423
In:
Anticancer research vol. 39
Availability: No items available.
|
|
|
3509.
|
Phase IB/II Study of Second-Line Therapy with Panitumumab, Irinotecan, and Everolimus (PIE) in [electronic resource] by
- Townsend, Amanda
- Tebbutt, Niall
- Karapetis, Christos
- Cooper, Pamela
- Singhal, Nimit
- Yeend, Susan
- Pirc, Louise
- Joshi, Rohit
- Hardingham, Jennifer
- Price, Timothy
Producer: 20191104
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
|
3510.
|
Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. [electronic resource] by
- Taghizadehghalehjoughi, Ali
- Hacimuftuoglu, Ahmet
- Cetin, Meltem
- Ugur, Afife Busra
- Galateanu, Bianca
- Mezhuev, Yaroslav
- Okkay, Ufuk
- Taspinar, Numan
- Taspinar, Mehmet
- Uyanik, Abdullah
- Gundogdu, Betul
- Mohammadzadeh, Maryam
- Nalci, Kemal Alp
- Stivaktakis, Polychronis
- Tsatsakis, Aristidis
- Jung, Tae Woo
- Jeong, Ji Hoon
- Abd El-Aty, A M
Producer: 20181211
In:
Nanomedicine (London, England) vol. 13
Availability: No items available.
|
|
|
3511.
|
|
|
|
3512.
|
|
|
|
3513.
|
|
|
|
3514.
|
Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. [electronic resource] by
- Bécouarn, Y
- Gamelin, E
- Coudert, B
- Négrier, S
- Pierga, J Y
- Raoul, J L
- Provençal, J
- Rixe, O
- Krisch, C
- Germa, C
- Bekradda, M
- Mignard, D
- Mousseau, M
Producer: 20011212
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
|
3515.
|
|
|
|
3516.
|
|
|
|
3517.
|
|
|
|
3518.
|
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). [electronic resource] by
- Van Cutsem, E
- Cunningham, D
- Ten Bokkel Huinink, W W
- Punt, C J
- Alexopoulos, C G
- Dirix, L
- Symann, M
- Blijham, G H
- Cholet, P
- Fillet, G
- Van Groeningen, C
- Vannetzel, J M
- Levi, F
- Panagos, G
- Unger, C
- Wils, J
- Cote, C
- Blanc, C
- Hérait, P
- Bleiberg, H
Producer: 19990427
In:
European journal of cancer (Oxford, England : 1990) vol. 35
Availability: No items available.
|
|
|
3519.
|
|
|
|
3520.
|
|